These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16739255)

  • 41. [Changes in the in vitro culture of peripheral blood cells of patients with acute leukosis during treatment with cytostatic preparations].
    Pospelova RA; Tsuladze GK
    Probl Gematol Pereliv Krovi; 1970 Aug; 15(8):43-6. PubMed ID: 5513860
    [No Abstract]   [Full Text] [Related]  

  • 42. [Bacterial flora in patients with acute leukemia during a specific treatment].
    Dronova OM; Smolianskaya AZ; Khvatova NV; Lorie IuI
    Probl Gematol Pereliv Krovi; 1971 Dec; 16(12):27-9. PubMed ID: 4945960
    [No Abstract]   [Full Text] [Related]  

  • 43. 6-Carboxyalkylthiopurine (buthiopurine, Cytogran Spofa).
    Semonský M; Cerny A
    Rev Czech Med; 1966; 12(2):103-15. PubMed ID: 5329419
    [No Abstract]   [Full Text] [Related]  

  • 44. Progress in the treatment of acute myeloid leukemia.
    Ravandi F; Burnett AK; Agura ED; Kantarjian HM
    Cancer; 2007 Nov; 110(9):1900-10. PubMed ID: 17786921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Principles and practice of clinical phase II studies].
    Dittrich C
    Onkologie; 2008; 31 Suppl 2():46-52. PubMed ID: 18487869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adult acute non-lymphocytic leukemias: current concepts and future directions.
    Katz ME
    Conn Med; 1980 Mar; 44(3):149-55. PubMed ID: 7363618
    [No Abstract]   [Full Text] [Related]  

  • 47. Acute leukemias.
    Hiddemann W
    Crit Rev Oncol Hematol; 2005 Nov; 56(2):193. PubMed ID: 16203157
    [No Abstract]   [Full Text] [Related]  

  • 48. Sorafenib in hepatocellular carcinoma: separating the hype from the hope.
    Kelley RK; Venook AP
    J Clin Oncol; 2008 Dec; 26(36):5845-8. PubMed ID: 19029408
    [No Abstract]   [Full Text] [Related]  

  • 49. Development of growth inhibitory agents in urological and other malignancies.
    Stadler WM
    BJU Int; 2006 Sep; 98(3):497-502. PubMed ID: 16827906
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluating the activity of temsirolimus in neuroendocrine cancer.
    O'Donnell PH; Ratain MJ
    Br J Cancer; 2007 Jan; 96(1):177; author reply 178-9. PubMed ID: 17164757
    [No Abstract]   [Full Text] [Related]  

  • 51. Ethical challenges in cancer research in children.
    Berg SL
    Oncologist; 2007 Nov; 12(11):1336-43. PubMed ID: 18055854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrin inhibitors reaching the clinic.
    Stupp R; Ruegg C
    J Clin Oncol; 2007 May; 25(13):1637-8. PubMed ID: 17470853
    [No Abstract]   [Full Text] [Related]  

  • 53. Patient heterogeneity in phase II studies of refractory disease in multiple myeloma--the 'spell' of the time to first relapse.
    Hermansen NE; Gimsing P
    Br J Haematol; 2008 Jan; 140(1):115-6. PubMed ID: 17894840
    [No Abstract]   [Full Text] [Related]  

  • 54. From laboratory to Phase I/II cancer trials with recombinant biotherapeutics.
    Tolner B; Smith L; Hillyer T; Bhatia J; Beckett P; Robson L; Sharma SK; Griffin N; Vervecken W; Contreras R; Pedley RB; Begent RH; Chester KA
    Eur J Cancer; 2007 Nov; 43(17):2515-22. PubMed ID: 17933516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel strategies for relapsed and refractory acute myeloid leukemia.
    Mato AR; Morgans A; Luger SM
    Curr Opin Hematol; 2008 Mar; 15(2):108-14. PubMed ID: 18300756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current treatment of acute leukemia].
    Bernard J; Boiron M; Jacquillat C; Najean Y; Seligmann M; Tanzer J; Weil M
    Presse Med (1893); 1966 May; 74(24):1241-5. PubMed ID: 5936080
    [No Abstract]   [Full Text] [Related]  

  • 57. Adaptive design may hasten clinical trials.
    Schmidt C
    J Natl Cancer Inst; 2007 Jan; 99(2):108-9. PubMed ID: 17227993
    [No Abstract]   [Full Text] [Related]  

  • 58. [Current treatments of acute leukemia].
    Bernard J
    Minerva Med; 1966 Mar; 57(25):1106-11. PubMed ID: 5932012
    [No Abstract]   [Full Text] [Related]  

  • 59. Ethics in phase II trials of cancer therapies.
    Davis M
    Perspectives Prof; 2000; 20(1):E1. PubMed ID: 15115038
    [No Abstract]   [Full Text] [Related]  

  • 60. Biphenotypic acute leukaemia: a case series.
    Aribi A; Bueso-Ramos C; Estey E; Estrov Z; O'Brien S; Giles F; Faderl S; Thomas D; Kebriaei P; Garcia-Manero G; Pierce S; Cortes J; Kantarjian H; Ravandi F
    Br J Haematol; 2007 Jul; 138(2):213-6. PubMed ID: 17593028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.